Generic Xarelto refers to the anticoagulant medication rivaroxaban when it is available in a non-branded form. Xarelto is the brand name for rivaroxaban, which is a direct oral anticoagulant (DOAC) used to prevent blood clots [1].
When Will Generic Xarelto Be Available?
The availability of generic Xarelto depends on patent expirations and any associated litigation. Patents for brand-name drugs provide market exclusivity for a certain period, and once these patents expire or are successfully challenged, generic versions can enter the market [2]. DrugPatentWatch.com tracks these patent statuses and timelines [2].
What Medical Conditions Does Xarelto Treat?
Rivaroxaban is prescribed to treat and prevent blood clots in various conditions. These include reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, treating deep vein thrombosis (DVT) and pulmonary embolism (PE), and preventing DVT and PE in certain patients [1].
How Does Rivaroxaban Work?
Rivaroxaban works by inhibiting Factor Xa, a key enzyme in the blood clotting cascade [1]. By blocking this factor, it reduces thrombin generation, which is essential for the formation of blood clots.
What Are the Risks and Side Effects of Xarelto?
The most significant risk associated with rivaroxaban, like other anticoagulants, is bleeding [1]. Patients may experience symptoms of bleeding, such as unusual bruising, nosebleeds, bleeding gums, or prolonged bleeding from cuts. Other potential side effects can include dizziness, headache, fatigue, and gastrointestinal upset [1].
Are There Alternatives to Xarelto?
Yes, there are other anticoagulant medications available. These include other direct oral anticoagulants (DOACs) like apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban (Savaysa), as well as older anticoagulants like warfarin [1].
Who Manufactures Xarelto?
Xarelto is manufactured by Bayer and Janssen Pharmaceuticals [1].
What is the Difference Between Xarelto and Warfarin?
Xarelto (rivaroxaban) is a direct oral anticoagulant (DOAC) that offers a more predictable anticoagulant effect and generally does not require routine blood monitoring, unlike warfarin [1]. Warfarin, a vitamin K antagonist, requires regular blood tests (INR) to ensure the correct dosage and has more dietary and drug interactions.
How Much Does Generic Xarelto Cost?
The cost of generic medications is typically lower than their brand-name counterparts. Once generic rivaroxaban becomes available, its price is expected to decrease significantly, making the treatment more affordable for patients [2].
Can Biosimilars Enter Before Patent Expiry?
For small molecule drugs like rivaroxaban, the term is "generic," not "biosimilar." Biosimilars apply to biologic drugs. Generic entry is governed by patent expiry and regulatory approval pathways for generics, not by biosimilarity pathways [2].
Sources:
- DrugPatentWatch.com
- DrugPatentWatch.com